Ken Griffin Oncology Institute, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 91,337 shares of TOI stock, worth $18,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,337
Previous 269,704
66.13%
Holding current value
$18,267
Previous $124,000
75.81%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TOI
# of Institutions
35Shares Held
17.5MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY3.36MShares$672,0100.02% of portfolio
-
Tiff Advisory Services Inc2.63MShares$526,5770.29% of portfolio
-
Cincinnati Insurance CO2.03MShares$406,8090.01% of portfolio
-
Kent Lake Pr LLC Anasco, PR2MShares$400,0000.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$356,6900.0% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $14.7M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...